In contrast to advanced disease, preoperative inflammatory markers (NLR, dNLR, PLR, and LDH) are not of prognostic value in non-metastatic high-risk Pca patients in terms of BCR-free survival. This evidence concerns the gene BCR and posterior cortical atrophy.